Platelet indexes in relation to target organ damage in high-risk hypertensive patients: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)
about
sameAs
The interaction of vasoactive substances during exercise modulates platelet aggregation in hypertension and coronary artery disease.Are platelet volume indices of clinical use? A multidisciplinary review.Platelet distribution width: a simple, practical and specific marker of activation of coagulationHigher platelet P-selectin in male patients with inflammatory bowel disease compared to healthy malesPlatelets and their chemokines in atherosclerosis-clinical applications.Gender dependence for a subset of the low-abundance signaling proteome in human platelets.Assessment of the relation between mean platelet volume, non-dipping blood pressure pattern, and left ventricular mass index in sustained hypertension.Mean platelet volume levels in the presence of angiographically documented peripheral artery diseaseAssessment of Mean Platelet Volume in Patients with Resistant Hypertension, Controlled Hypertension and Normotensives.Association between high platelet indices and proteinuria in patients with hypertensionCirculating levels of cell adhesion molecules in hypertensionRelationship of Hypertensive Retinopathy with Mean Platelet Volume Among Hypertensive PatientsImpact of Mean Platelet Volume on Long-Term Mortality in Chinese Patients with ST-Elevation Myocardial InfarctionP‑selectin increases angiotensin II‑induced cardiac inflammation and fibrosis via platelet activation.Inhibition of platelet activation by clopidogrel prevents hypertension-induced cardiac inflammation and fibrosis.Inflammation, hemostasis, and the risk of kidney function decline in the Atherosclerosis Risk in Communities (ARIC) Study.Relationship between mean platelet volume and morning blood pressure surge in newly diagnosed hypertensive patients.The potential role of milk-derived peptides in cardiovascular disease.Serum uric acid levels and inflammatory markers with respect to dipping status: A retrospective analysis of hypertensive patients with or without chronic kidney disease.Polymorphisms of inflammatory markers and risk of essential hypertension in Tatars from Russia.Relationship between renal function and circulating microparticles, soluble P-selectin and E-selectin levels in atrial fibrillation.Decreased platelet nitric oxide contributes to increased circulating monocyte-platelet aggregates in hypertension.The mean platelet volume in patients with non-dipper hypertension compared to dippers and normotensives.Platelet activation in essential hypertension: implications for antiplatelet treatment.Mean platelet volume in patients with dipper and non-dipper hypertension.Impact of mean platelet volume on the occurrence and severity of sudden sensorineural hearing loss.Increased platelet volume in a general population with prehypertension: a cross-sectional study of 80 545 participants from China.Mean platelet volume and abnormal left ventricle geometric patterns in patients with untreated essential hypertension.Prognostic value of platelet indices as determined by ADVIA 120 in patients suspected of having disseminated intravascular coagulation.Mean platelet volume is increased in patients with hypertensive crises.Pro-inflammatory role of platelets in hypertension-mediated end-organ damage : Editorial to: "Inhibition of Platelet activation by clopidogrel prevents hypertension-induced cardiac inflammation and fibrosis" by L.-X. Jia et al.Association of hematological parameters with metabolic syndrome in Beijing adult population: a longitudinal study.Lifestyle modification decreases the mean platelet volume in prehypertensive patients.Increased mean platelet volume in patients with slow coronary flow.Hypertension is an independent predictor of mean platelet volume in patients with acute ischaemic stroke.Impact of the therapy by renin-angiotensin system targeting antihypertensive agents perindopril versus telmisartan on prothrombotic state in essential hypertension.Could platelet distribution width be a predictive marker for unexplained recurrent miscarriage?Can Plateletcrit be a Marker for Recurrent Pregnancy Loss?Central aortic pulse pressure, thrombogenicity and cardiovascular risk.Platelet distribution width and the extent of coronary artery disease: results from a large prospective study.
P2860
Q33337940-D419DA9C-3411-418D-81E7-9630BA0F15F5Q33400229-A4AB8212-6073-4716-A063-EBACBAD354D2Q33745568-B7B40D31-4936-4FEA-B4D6-5C0717279137Q34013198-C04E18B1-FADD-421D-95C6-6D724EEDF749Q34019069-9D914D01-D778-4E7F-89D4-7D913CAE385AQ34219541-DF225434-7F95-4EBB-8A65-0D86283A6678Q34432817-F96F9E56-0C53-4D14-A08B-FA5D193789CFQ35481656-34C5AB94-1533-47C8-8A0E-BB6096AF6B7FQ35827524-81019A0A-8E41-4754-ADAE-E26D8FECE143Q36083714-0F8ACFDF-DFCA-41A9-BA26-165FF63FCEF6Q36262961-E0A3C1A4-131E-45CB-9BFA-73B2BF04BAA6Q36500078-3CBDE17E-BB55-40F0-8B49-F524E5C29709Q36583874-4154FA98-983F-461D-A6DA-27B09F6A0E25Q36931296-D6641714-8D17-4022-98D6-383E6F72202DQ37314369-E3669BB4-2195-45D0-BF3B-D3DE9DD63CA0Q37423232-254DCA8B-9A36-4DD9-A66B-69E58AB0EB10Q37680596-A3E7F39C-8D5A-4029-96CE-280DC10AC18CQ37903711-4ADDA020-FC52-492C-BA46-542EF7715A81Q40661201-7C6D6256-E2CB-4926-A8E1-8D745D97DE82Q41758606-1B3AED4E-131F-4C62-8A58-3A3C1F5E8044Q41964553-471C43E4-DF33-4AAB-AF13-874843EE57F8Q42458586-B1DBF269-ED83-48F5-A29E-BDEFDD35EBD8Q43109518-102D138B-C447-4EAF-829E-421EFC37A303Q43186392-EE2FDA07-D4B0-4C5D-8CD9-3EB8BE8320E4Q43446619-2EB91233-2002-4AD5-929E-08D60DD9F5CFQ43744643-E253AE9A-7BFF-4951-A5EF-C4DF0EC4A5E4Q44241310-06E6507D-E46F-4C6C-A93F-A81765FF82B4Q44552747-EDEB58C8-C86E-4E46-B02A-6F07881590DCQ44565965-F1DB7E22-7DF4-4FA7-A5C5-F9C5B5D84AA4Q45296178-42F9B590-D8A2-4508-BA14-1A7775DA1857Q45729733-82D08232-A3D8-4352-B709-DCF8CEC78667Q45731699-AAEBC792-F4F8-4EE9-A6B2-A14D280C50A6Q46145101-F643ACC0-004E-42F0-A45B-37BB0BE17A56Q46145111-2353F708-51A5-4A05-B69A-CA6699137084Q46570310-23CCD755-E2E5-4B76-8E62-802097B7B917Q46729379-09296B44-5C2C-4FB8-ABCE-5111C3BA9B77Q46732914-48864A10-5117-4A71-80C4-97C9B3D81EBBQ50454207-47506FFA-2A29-4A9E-A321-E7A78E308108Q50536660-A5772F33-5D94-4214-9E8F-0DCA8D6B6396Q50559798-5938F45E-3F02-416C-8727-2D4A584F2AED
P2860
Platelet indexes in relation to target organ damage in high-risk hypertensive patients: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)
description
2004 nî lūn-bûn
@nan
2004 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Platelet indexes in relation t ...... Cardiac Outcomes Trial (ASCOT)
@ast
Platelet indexes in relation t ...... Cardiac Outcomes Trial (ASCOT)
@en
Platelet indexes in relation t ...... Cardiac Outcomes Trial (ASCOT)
@nl
type
label
Platelet indexes in relation t ...... Cardiac Outcomes Trial (ASCOT)
@ast
Platelet indexes in relation t ...... Cardiac Outcomes Trial (ASCOT)
@en
Platelet indexes in relation t ...... Cardiac Outcomes Trial (ASCOT)
@nl
prefLabel
Platelet indexes in relation t ...... Cardiac Outcomes Trial (ASCOT)
@ast
Platelet indexes in relation t ...... Cardiac Outcomes Trial (ASCOT)
@en
Platelet indexes in relation t ...... Cardiac Outcomes Trial (ASCOT)
@nl
P2093
P3181
P1476
Platelet indexes in relation t ...... Cardiac Outcomes Trial (ASCOT)
@en
P2093
Andrew D Blann
D Gareth Beevers
Sridhar Kamath
Sunil K Nadar
P304
P3181
P356
10.1016/J.JACC.2004.03.067
P407
P577
2004-07-21T00:00:00Z